Access Bio Inc (KQ:950130) — Market Cap & Net Worth
Market Cap & Net Worth: Access Bio Inc (950130)
Access Bio Inc (KQ:950130) has a market capitalization of $51.25 Million (₩75.62 Billion) as of August 1, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #21720 globally and #1276 in its home market, demonstrating a -6.72% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Access Bio Inc's stock price ₩2150.00 by its total outstanding shares 35173800 (35.17 Million). See Access Bio Inc capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Access Bio Inc Market Cap History: 2015 to 2026
Access Bio Inc's market capitalization history from 2015 to 2026. Data shows change from $172.10 Million to $51.25 Million (-12.80% CAGR).
Access Bio Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Access Bio Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.50x
Access Bio Inc's market cap is 1.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $172.10 Million | $35.58 Billion | $1.26 Billion | 0.00x | 0.14x |
| 2016 | $145.88 Million | $27.99 Million | $262.09K | 5.21x | 556.61x |
| 2017 | $109.17 Million | $26.06 Million | -$5.74 Million | 4.19x | N/A |
| 2018 | $102.14 Million | $36.57 Million | -$3.85 Million | 2.79x | N/A |
| 2019 | $93.44 Million | $36.94 Million | -$15.09 Million | 2.53x | N/A |
| 2021 | $381.39 Million | $441.37 Million | $165.75 Million | 0.86x | 2.30x |
| 2022 | $290.81 Million | $800.23 Million | $268.33 Million | 0.36x | 1.08x |
| 2023 | $213.82 Million | $267.08 Million | -$2.43 Million | 0.80x | N/A |
| 2024 | $123.71 Million | $82.45 Million | -$254.83K | 1.50x | N/A |
Competitor Companies of 950130 by Market Capitalization
Companies near Access Bio Inc in the global market cap rankings as of August 1, 2026.
Key companies related to Access Bio Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $215.77 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #169 globally with a market cap of $137.72 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #577 globally with a market cap of $46.48 Billion USD ( CN¥317.64 Billion CNY).
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #616 globally with a market cap of $43.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $215.77 Billion | $574.30 |
| #169 | Danaher Corporation | NYSE:DHR | $137.72 Billion | $194.98 |
| #577 | WuXi AppTec Co Ltd | SHG:603259 | $46.48 Billion | CN¥128.43 |
| #616 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.83 Billion | $559.07 |
Access Bio Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Access Bio Inc's market cap moved from $172.10 Million to $ 51.25 Million, with a yearly change of -12.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩51.25 Million | -59.13% |
| 2025 | ₩125.38 Million | +1.35% |
| 2024 | ₩123.71 Million | -42.14% |
| 2023 | ₩213.82 Million | -26.48% |
| 2022 | ₩290.81 Million | -23.75% |
| 2021 | ₩381.39 Million | +308.16% |
| 2019 | ₩93.44 Million | -8.52% |
| 2018 | ₩102.14 Million | -6.44% |
| 2017 | ₩109.17 Million | -25.16% |
| 2016 | ₩145.88 Million | -15.24% |
| 2015 | ₩172.10 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Access Bio Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $51.25 Million USD |
| MoneyControl | $51.25 Million USD |
| MarketWatch | $51.25 Million USD |
| marketcap.company | $51.25 Million USD |
| Reuters | $51.25 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Access Bio Inc
Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities wi… Read more